Who Paid My Doc
Michele Spencer-Manzon
Clinical Biochemical Genetics New Haven, CT Medical Doctor
NPI 1861667065 CMS profile 871631
20 York St, New Haven, CT 06510
General payments
$11,690
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$156,424
Through program year 2025, Michele Spencer-Manzon of New Haven, CT is reported in the CMS Open Payments database as having received $11,690 across 13 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $156,424 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $2,132 | 1 | |
| 2024 | General | $2,100 | 1 | |
| 2023 | General | $1,000 | 1 | |
| 2022 | General | $30 | 1 | |
| 2020 | General | $6,409 | 4 | |
| 2019 | General | $19 | 5 |
Beside peers
- Michele Spencer-Manzon
- Clinical Biochemical Genetics median
- Middle half of Clinical Biochemical Genetics
- National median
In program year 2025, general payments to Michele Spencer-Manzon were reported at $2,132. Among 23 Clinical Biochemical Genetics profiles paid that year, the median was $237 and the middle half received between $88 and $2,648.
Show as a table
| Year | Michele Spencer-Manzon | Clinical Biochemical Genetics median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $19 | $132 | $20–$1,451 | $163 |
| 2020 | $6,409 | — | — | $114 |
| 2021 | $0 | — | — | $132 |
| 2022 | $30 | $157 | $94–$2,848 | $149 |
| 2023 | $1,000 | $242 | $71–$1,706 | $160 |
| 2024 | $2,100 | — | — | $164 |
| 2025 | $2,132 | $237 | $88–$2,648 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
13 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Clinical Biochemical Genetics in Connecticut
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Biochemical Genetics
Everyone recorded under this specialty, nationwide.
Doctors in Connecticut
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.